参考文献/References:
[1] Goldstein BA,Thomas L,Zaroff JG,et al. Assessment of heart transplant waitlist time and pre- and post-transplant failure:a mixed methods approach[J]. Epidemiology,2016,27(4):469-476.
[2] Khush KK,Zaroff JG,Nguyen J,et al. National decline in donor heart utilization with regional variability:1995-2010[J]. Am J Transplant,2015,15(3):642-649.
[3]Dick SA,Macklin JA,Nejat S,et al. Self-renewing resident cardiac macrophages limit adverse remodeling following myocardial infarction[J]. Nat Immunol,2019,20(1):29-39.
[4]Bajpai G,Bredemeyer A,Li W,et al. Tissue resident CCR2- and CCR2+ cardiac macrophages differentially orchestrate monocyte recruitment and fate specification following myocardial injury [J]. Circ Res,2019,124(2):263-278.
[5]Chiu S,Bharat A. Role of monocytes and macrophages in regulating immune response following lung transplantation[J]. Curr Opin Organ Transplant,2016,21(3):239-245.
[6]Hsiao HM,Fernandez R,Tanaka S,et al. Spleen-derived classical monocytes mediate lung ischemia-reperfusion injury through IL-1β[J]. J Clin Invest,2018,128(7):2833-2847.
[7]Misharin AV,Morales-Nebreda L,Reyfman PA,et al. Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span[J]. J Exp Med,2017,214(8):2387-2404.
[8]Nayak DK,Zhou F,Xu M,et al. Long-term persistence of donor alveolar macrophages in human lung transplant recipients that influences donor-specific immune responses[J]. Am J Transplant,2016,16(8):2300-2311.
[9]Eguíluz-Gracia I,Schultz HH,Sikkeland LI,et al. Long-term persistence of human donor alveolar macrophages in lung transplant recipients[J]. Thorax,2016,71(11):1006-1011.
[10]Nicoara A,Ruffin D,Cooter M,et al. Primary graft dysfunction after heart transplantation:incidence,trends,and associated risk factors[J]. Am J Transplant,2018,18(6):1461-1470.
[11]Dhuriya YK,Sharma D. Necroptosis:a regulated inflammatory mode of cell death[J]. J Neuroinflammation,2018,15(1):199.
[12]van den Bosch TP,Caliskan K,Kraaij MD,et al. CD16+ monocytes and skewed macrophage polarization toward M2 type hallmark heart transplant acute cellular rejection[J]. Front Immunol,2017,8:346.
[13]Liu Y,Kloc M,Li XC. Macrophages as effectors of acute and chronic allograft injury[J]. Curr Transplant Rep,2016,3(4):303-312.
[14]Loupy A,Hidalgo L,Duong JP,et al. Response by Loupy et al to letters regarding article,"gene expression profiling for the identification and classification of antibody-mediated heart rejection"[J]. Circulation,2017,136(7):698-699.
[15]Pabois A,Pagie S,Gerard N,et al. Notch signaling mediates crosstalk between endothelial cells and macrophages via Dll4 and IL6 in cardiac microvascular inflammation[J]. Biochem Pharmacol,2016,104:95-107.
[16]Braza MS,van Leent MMT,Lameijer M,et al. Inhibiting inflammation with myeloid cellspecific nanobiologics promotes organ transplant acceptance[J]. Immunity,2018,49(5):819-828e6.
[17]Xie Y,Tolmeijer S,Oskam JM,et al. Glucocorticoids inhibit macrophage differentiation towards a pro-inflammatory phenotype upon wounding without affecting their migration[J]. Dis Model Mech,2019,12(5):dmm037887.
[18]Braza MS,conde P,Garcia M,et al. Neutrophil derived CSF1 induces macrophage polarization and promotes transplantation tolerance[J]. Am J Transplant,2018,18(5):1247-1255.
[19]Zhao Y,Chen S,Lan P,et al. Macrophage subpopulations and their impact on chronic allograft rejection versus graft acceptance in a mouse heart transplant model[J]. Am J Transplant,2018,18(3):604-616.
[20]Salehi S,Reed EF. The divergent roles of macrophages in solid organ transplantation[J]. Curr Opin Organ Transplant,2015,20(4):446-453.
[21]de Graav GN,Bergan S,Baan CC,et al. Therapeutic drug monitoring of belatacept in kidney transplantation[J]. Ther Drug Monit,2015,37(5):560-567.
[22]Wu YL,Ye Q,Eytan DF,et al. Magnetic resonance imaging investigation of macrophages in acute cardiac allograft rejection after heart transplantation[J]. Circ Cardiovasc Imaging,2013,6(6):965-973.
[23]Pajaro OE,Jaroszewski DE,Scott RL,et al. Antibody-mediated rejection in heart transplantation:case presentation with a review of current international guidelines[J]. J Transplant,2011,2011:351950.
[24]Sica A,Mantovani A. Macrophage plasticity and polarization:in vivo veritas[J]. J Clin Invest,2012,122(3):787-795.
相似文献/References:
[1]张伟 黄从新.巨噬细胞与心血管稳态和疾病[J].心血管病学进展,2019,(9):1241.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.014]
ZHANG Wei,HUANG Congxin.Macrophages are Associated with Cardiovascular Homeostasis and Diseases[J].Advances in Cardiovascular Diseases,2019,(6):1241.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.014]
[2]李一凡 张智伟.巨噬细胞相关的外泌体在心血管疾病中的作用研究进展[J].心血管病学进展,2020,(8):839.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.014]
LI Yifan,ZHANG Zhiwei.Role of Macrophage-Related Exosomes in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2020,(6):839.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.014]
[3]付韫韬 赵庆彦?/html>.巨噬细胞调控离子通道致心律失常研究的最新进展[J].心血管病学进展,2022,(2):100.[doi:10.16806/j.cnki.issn.1004-3934.2022.02.002]
FU Yuntao ZHAO Qingyan.Macrophages Regulating Ion Channels to Induce Arrhythmia[J].Advances in Cardiovascular Diseases,2022,(6):100.[doi:10.16806/j.cnki.issn.1004-3934.2022.02.002]
[4]陈乾 秦铭 徐志云.单核/巨噬细胞与主动脉瓣钙化研究进展[J].心血管病学进展,2022,(10):898.[doi:10.16806/j.cnki.issn.1004-3934.2022.10.008]
CHEN Qian,QIN Ming,XU Zhiyun.Aortic Valve Calcification Caused by Mononuclear Phagocyte System[J].Advances in Cardiovascular Diseases,2022,(6):898.[doi:10.16806/j.cnki.issn.1004-3934.2022.10.008]
[5]王朝阳 赵丽娜 田师鹏 陈淑霞 谷剑.炎症治疗在动脉粥样硬化中的研究进展[J].心血管病学进展,2023,(6):519.[doi:10.16806/j.cnki.issn.1004-3934.2023.06.009]
WANG Zhaoyang,ZHAO Lina,TIAN Shipeng,et al.Advances in the Treatment of Inflammation in Atherosclerosis[J].Advances in Cardiovascular Diseases,2023,(6):519.[doi:10.16806/j.cnki.issn.1004-3934.2023.06.009]
[6]黄爱宝??少衡.巨噬细胞治疗缺血心肌的研究进展[J].心血管病学进展,2024,(6):543.[doi:10.16806/j.cnki.issn.1004-3934.2024.06.015]
HUANG Aibao,ZHANG Shaoheng?/html>.Research progress in Macrophage Therapy for?schemic Myocardium[J].Advances in Cardiovascular Diseases,2024,(6):543.[doi:10.16806/j.cnki.issn.1004-3934.2024.06.015]